10x Genomics (TXG) Other Working Capital Changes (2018 - 2026)

10x Genomics has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $77000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $77000.0, down 98.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.8 million (down 319.48% YoY), and the FY2025 annual result was -$10.3 million, down 642.35% from the prior year.
• Other Working Capital Changes came in at $77000.0 for Q1 2026 at 10x Genomics, up from -$2.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $5.5 million in Q1 2025 to a low of -$6.7 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is -$43000.0 (2023), against an average of -$519411.8.
• Across the five-year window, Other Working Capital Changes surged 3018.6% in 2024 and sank 4342.67% in 2025, its largest moves.
• 10x Genomics' Other Working Capital Changes stood at -$2.0 million in 2022, then surged by 97.9% to -$43000.0 in 2023, then soared by 3018.6% to $1.3 million in 2024, then sank by 316.73% to -$2.7 million in 2025, then surged by 102.83% to $77000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $77000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$6.7 million (Q3 2025), per Business Quant data.